KLRK1 and neoplasm: For example, metastatic tumor cells often shed the NKG2D ligand of MICA and MICB proteins [141] through proteolytic proteins such as ADAM10, ADAM17, and MMP14 [142,143], thereby producing soluble variants of ligands, acting as molecular decoys for blocking NK cell activation [144,145].